Skip to content
10-K

Annual Report

INTEC PHARMA LTD.

0001213900-21-015763

← back to feed
Filed
Mar 16, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Capex FY 2020 · Dec 31, 2020 $22K
Capex FY 2020 · Dec 31, 2019 $921K
Operating Cash Flow FY 2020 · Dec 31, 2020 −$11.51M
Operating Cash Flow FY 2020 · Dec 31, 2019 −$29.05M
Cash And Equivalents FY 2020 · Dec 31, 2020 $14.67M
Cash And Equivalents FY 2020 · Dec 31, 2019 $9.29M
Cash And Equivalents FY 2020 · Dec 31, 2018 $39.25M
Stockholders Equity FY 2020 · Dec 31, 2020 $14.53M
Stockholders Equity FY 2020 · Dec 31, 2019 $11.54M
Stockholders Equity FY 2020 · Dec 31, 2018 $53.55M
Current Liabilities FY 2020 · Dec 31, 2020 $5.33M
Current Liabilities FY 2020 · Dec 31, 2019 $8.34M
Total Liabilities FY 2020 · Dec 31, 2020 $6.36M
Total Liabilities FY 2020 · Dec 31, 2019 $9.75M
Current Assets FY 2020 · Dec 31, 2020 $14.97M
Current Assets FY 2020 · Dec 31, 2019 $13.75M
Total Assets FY 2020 · Dec 31, 2020 $20.9M
Total Assets FY 2020 · Dec 31, 2019 $21.28M
Sga Expense FY 2020 · Dec 31, 2020 $7.09M
Sga Expense FY 2020 · Dec 31, 2019 $8.29M
Rd Expense FY 2020 · Dec 31, 2020 $6.74M
Rd Expense FY 2020 · Dec 31, 2019 $26.66M
Net Income FY 2020 · Dec 31, 2020 −$14.13M
Net Income FY 2020 · Dec 31, 2019 −$47.6M
Operating Income FY 2020 · Dec 31, 2020 −$13.83M
Operating Income FY 2020 · Dec 31, 2019 −$47.11M